Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review
- PMID: 38415810
- DOI: 10.1111/hel.13057
Primary antibiotic resistance of Helicobacter pylori in India over the past two decades: A systematic review
Abstract
Background: Helicobacter pylori antibiotic resistance has undergone vast changes in the last two decades. No systematic review has been done on the prevalence of antibiotic resistant H. pylori in India in the last two decades. We evaluated the pattern of resistance rates across various regions of India.
Materials and methods: A systematic review of the geographical variations in antibiotic resistance pattern of H. pylori was conducted using PubMed, Google Scholar, Web of Science, Science Direct, etc. for articles published between January 1, 2000 and May 30, 2023. Random effects-model-based Cochran's Q test, I2 statistics, and chi-squared tests were used to measure heterogeneity.
Results: The overall resistance was highest against metronidazole (77.65%) followed by amoxicillin (37.78%), levofloxacin (32.8%), clarithromycin (35.64%), furazolidone (12.03%), and tetracycline (11.63%). 14.7% of the H. pylori isolates were multi-drug resistant. Under meta-analysis of each antibiotic, high heterogeneity levels were observed having I2 ranges from 86.53% to 97.70% at p < 0.0001. In sub-group analysis, Metronidazole has a stable rate of resistance as compared to other antibiotics. Other antibiotics have had a downtrend in the last 5 years except for levofloxacin, which has had an uptrend in the resistance rate for the past 5 years. Hence, one should avoid using metronidazole for any kind of first-line treatment.
Conclusions: Metronidazole resistance is high in most regions of India except Assam and Mumbai while clarithromycin is found to be ineffective in South India, Gujarat, and Kashmir. As compared to other antibiotics, resistance to amoxicillin is generally low except in certain regions (Hyderabad, Chennai, and the Gangetic belt of North India). Tetracycline and Furazolidone have the least resistance rates and should be part of anti- H. pylori regimens. The resurgence of high single and multidrug resistance to the commonly used drugs suggests the need for newer antibiotics and regular resistance surveillance studies.
Keywords: Helicobacter pylori; Antibiotic resistance; Systematic review.
© 2024 John Wiley & Sons Ltd.
Similar articles
-
Helicobacter pylori and gastric or duodenal ulcer.Prescrire Int. 2016 Jan;25(167):18-23. Prescrire Int. 2016. PMID: 26942258
-
Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis.Lancet Gastroenterol Hepatol. 2017 Oct;2(10):707-715. doi: 10.1016/S2468-1253(17)30219-4. Epub 2017 Aug 7. Lancet Gastroenterol Hepatol. 2017. PMID: 28781119
-
Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure.PLoS One. 2022 Apr 20;17(4):e0265322. doi: 10.1371/journal.pone.0265322. eCollection 2022. PLoS One. 2022. PMID: 35442962 Free PMC article.
-
Prevalence of Primary Antimicrobial Resistance of H. pylori in Turkey: A Systematic Review.Helicobacter. 2016 Aug;21(4):251-60. doi: 10.1111/hel.12272. Epub 2015 Sep 23. Helicobacter. 2016. PMID: 26395982
-
Efficacy of bismuth for antibiotic-resistant Helicobacter pylori strains eradication: A systematic review and meta-analysis.Helicobacter. 2022 Dec;27(6):e12930. doi: 10.1111/hel.12930. Epub 2022 Sep 25. Helicobacter. 2022. PMID: 36156332
Cited by
-
Prospective Evaluation of a New Liquid-Type Rapid Urease Test Kit for Diagnosis of Helicobacter pylori.Diagnostics (Basel). 2024 Mar 27;14(7):700. doi: 10.3390/diagnostics14070700. Diagnostics (Basel). 2024. PMID: 38611613 Free PMC article.
-
Overcoming antibiotic-resistant Helicobacter pylori infection: Current challenges and emerging approaches.World J Gastroenterol. 2025 Mar 14;31(10):102289. doi: 10.3748/wjg.v31.i10.102289. World J Gastroenterol. 2025. PMID: 40093672 Free PMC article. Review.
-
Looking Back, Moving Forward: Challenges and Opportunities for Global Cervical Cancer Prevention and Control.Viruses. 2024 Aug 25;16(9):1357. doi: 10.3390/v16091357. Viruses. 2024. PMID: 39339834 Free PMC article. Review.
References
REFERENCES
-
- Datta S, Chattopadhyay S, Patra R, et al. Most Helicobacter pylori strains of Kolkata in India are resistant to metronidazole but susceptible to other drugs commonly used for eradication and ulcer therapy. Aliment Pharmacol Ther. 2005;22(1):51-57. doi:10.1111/j.1365-2036.2005.02533.x
-
- Gehlot V, Mahant S, Mukhopadhyay AK, et al. Low prevalence of clarithromycin-resistant Helicobacter pylori isolates with A2143G point mutation in the 23S rRNA gene in North India. J Glob Antimicrob Resist. 2016;6:39-43. doi:10.1016/j.jgar.2016.02.007
-
- Gehlot V, Mahant S, Mukhopadhyay AK, et al. Antimicrobial susceptibility profiles of Helicobacter pylori isolated from patients in North India. J Glob Antimicrob Resist. 2016;5:51-56. doi:10.1016/j.jgar.2015.09.009
-
- Singh SP, Ahuja V, Ghoshal UC, et al. Management of Helicobacter pylori infection: the Bhubaneswar consensus report of the Indian Society of Gastroenterology. Indian J Gastroenterol. 2021;40(4):420-444. doi:10.1007/s12664-021-01186-4
-
- Alba C, Blanco AL, Alarcón T. Antibiotic resistance in Helicobacter pylori. Curr Opin Infect Dis. 2017;30(5):489-497. doi:10.1097/qco.0000000000000396
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous